Flores, Eduardo P.

HRN: 21-52-67  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/06/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/06/2022
07/14/2022
IVT
500mg
Q8
Fungating Mass R Gluteal Area With Multiple Fistula
Waiting Final Action 

Indication:  Empiric    Type of Infection:  BloodstreamSkin & Soft Tissue    Compliance to guidelines: Guideline Not Available

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: